Form 4 Tracker
Dianthus Therapeutics, Inc. /DE/
DNTH

32 insider filings · Latest: Sep 17, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Sep 17, 2026Sep 18 8:36 PMEdward CarrCHIEF ACCOUNTING OFFICER
Sale
20,000$101.38$2.0M0(D)

View →

Sep 17, 2026Sep 17 8:28 PMEDWARD CARR
Proposed Sale
20,000$102.49$2.0M—

View →

Sep 1, 2026Sep 3 8:30 PMSimrat RandhawaEVP, Head of R&D
Sale
23,124$106.41$2.5M4,000(D)

View →

Sep 1, 2026Sep 1 8:49 PMSIMRAT RANDHAWA
Proposed Sale
23,124$105.61$2.4M—

View →

Aug 19, 2026Aug 19 10:02 PMSimon ReadDirector
Sale
2,778$117.55$326.6K0(D)

View →

Aug 10, 2026Aug 11 9:15 PMAnne McgeorgeDirector
Sale
7,750$109.01$844.8K0(D)

View →

Aug 10, 2026Aug 11 9:10 PMSimon ReadDirector
Sale
2,777$109.55$304.2K0(D)

View →

Aug 10, 2026Aug 11 9:08 PMAdam M VenessSVP, General Counsel and Sec.
Sale
16,167$110.38$1.8M0(D)

View →

Aug 7, 2026Aug 11 9:08 PMAdam M VenessSVP, General Counsel and Sec.
Sale
3,833$110.70$424.3K0(D)

View →

Aug 10, 2026Aug 10 8:50 PMADAM VENESS
Proposed Sale
16,167$108.92$1.8M—

View →

Aug 10, 2026Aug 10 8:34 PMRead Simon
Proposed Sale
5,550$112.50$624.4K—

View →

Aug 10, 2026Aug 10 8:33 PMANNE M MCGEORGE
Proposed Sale
7,750$108.92$844.1K—

View →

Aug 7, 2026Aug 7 10:30 PMMarino GarciaDirector, CEO AND PRESIDENT
Sale
166,000$108.11$17.9M65,292(D)

View →

Aug 7, 2026Aug 7 8:38 PMMARINO GARCIA
Proposed Sale
40,000$109.92$4.4M—

View →

Aug 7, 2026Aug 7 8:37 PMADAM VENESS
Proposed Sale
3,833$109.92$421.3K—

View →

Aug 7, 2026Aug 7 8:18 PMMARINO GARCIA
Proposed Sale
126,000$108.09$13.6M—

View →

Jul 9, 2026Jul 13 9:00 PMRyan SavitzEVP, CFO & CBO
Sale
31,249$101.03$3.2M0(D)

View →

Jul 9, 2026Jul 9 8:26 PMRYAN SAVITZ
Proposed Sale
31,249$98.07$3.1M—

View →

Jun 17, 2026Jun 18 8:30 PMAdam M VenessSVP, General Counsel and Sec.
Sale
30,000$80.80$2.4M0(D)

View →

Jun 17, 2026Jun 17 8:33 PMADAM M VENESS
Proposed Sale
30,000$78.88$2.4M—

View →

Page 1 of 2

Next →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Sep 17, 2026Sep 18 8:36 PMEdward CarrCHIEF ACCOUNTING OFFICER
Option Exercise
20,000$17.8843,818(D)

View →

Sep 1, 2026Sep 3 8:30 PMSimrat RandhawaEVP, Head of R&D
Option Exercise
23,124$22.0787,500(D)

View →

Aug 19, 2026Aug 19 10:02 PMSimon ReadDirector
Option Exercise
2,778$18.3619,445(D)

View →

Aug 13, 2026Aug 14 8:30 PMAdam M VenessSVP, General Counsel and Sec.
Option Exercise
15,000$18.1773,240(D)

View →

Aug 10, 2026Aug 11 9:15 PMAnne McgeorgeDirector
Option Exercise
7,750$19.360(D)

View →

Aug 10, 2026Aug 11 9:10 PMSimon ReadDirector
Option Exercise
2,777$18.3622,223(D)

View →

Aug 10, 2026Aug 11 9:08 PMAdam M VenessSVP, General Counsel and Sec.
Option Exercise
16,167$17.8860,000(D)

View →

Aug 7, 2026Aug 11 9:08 PMAdam M VenessSVP, General Counsel and Sec.
Option Exercise
3,833$17.8876,167(D)

View →

Aug 7, 2026Aug 7 10:30 PMMarino GarciaDirector, CEO AND PRESIDENT
Option Exercise
166,000$8.44160,004(D)

View →

Jul 9, 2026Jul 13 9:00 PMRyan SavitzEVP, CFO & CBO
Option Exercise
31,249$21.7768,751(D)

View →

Jun 17, 2026Jun 18 8:30 PMAdam M VenessSVP, General Counsel and Sec.
Option Exercise
30,000$17.8880,000(D)

View →

Jun 1, 2026Jun 2 11:00 PMSimrat RandhawaEVP, Head of R&D
Option Exercise
26,530$22.0796,875(D)

View →

May 21, 2026May 22 8:30 PMSteven J. RomanoDirector
Grant/Award
6,090$89.636,090(D)

View →

May 21, 2026May 22 8:30 PMSimon ReadDirector
Grant/Award
6,090$89.636,090(D)

View →

May 21, 2026May 22 8:30 PMAlison Frances LawtonDirector
Grant/Award
6,090$89.636,090(D)

View →

May 21, 2026May 22 8:30 PMAnne McgeorgeDirector
Grant/Award
6,090$89.636,090(D)

View →

May 21, 2026May 22 8:30 PMSujay KangoDirector
Grant/Award
6,090$89.636,090(D)

View →

May 21, 2026May 22 8:30 PMJonathan ViolinDirector
Grant/Award
6,090$89.636,090(D)

View →

May 21, 2026May 22 8:30 PMPaula SoteropoulosDirector
Grant/Award
6,090$89.636,090(D)

View →

May 8, 2026May 11 9:00 PMPaula SoteropoulosDirector
Option Exercise
599$8.440(D)

View →

Page 1 of 2

Next →